Crescent Capital BDC (CCAP)
(Delayed Data from NSDQ)
$18.36 USD
+0.08 (0.44%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.33 -0.03 (-0.16%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Income Statements
Fiscal Year end for Crescent Capital BDC, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 184 | 117 | 94 | 77 | 53 |
Cost Of Goods | 59 | 32 | 20 | 15 | 13 |
Gross Profit | 125 | 85 | 74 | 62 | 40 |
Selling & Adminstrative & Depr. & Amort Expenses | 42 | 31 | 18 | 11 | 8 |
Income After Depreciation & Amortization | 84 | 54 | 56 | 50 | 32 |
Non-Operating Income | 0 | 6 | -6 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 84 | 60 | 50 | 50 | 32 |
Income Taxes | 1 | 0 | 2 | 1 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 1 | -44 | 36 | 5 | -2 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 84 | 16 | 84 | 55 | 29 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 84 | 16 | 84 | 55 | 29 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 79 | 48 | 47 | 47 | 30 |
Depreciation & Amortization (Cash Flow) | -5 | -5 | -9 | -4 | -2 |
Income After Depreciation & Amortization | 84 | 54 | 56 | 50 | 32 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 35.93 | 30.89 | 28.48 | 27.68 | 17.35 |
Diluted EPS Before Non-Recurring Items | 2.30 | 1.93 | 1.67 | 1.80 | 1.82 |
Diluted Net EPS (GAAP) | 2.33 | 0.50 | 2.94 | 1.98 | 1.69 |
Fiscal Year end for Crescent Capital BDC, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 48.95 | 50.36 | 49.96 | 48.15 | 46.74 |
Cost Of Goods | 15.93 | 15.60 | 15.72 | 15.38 | 15.27 |
Gross Profit | 33.02 | 34.76 | 34.24 | 32.77 | 31.47 |
SG&A, R&D, and Dept/Amort Expenses | 10.88 | 11.07 | 11.07 | 10.70 | 10.56 |
Income After SG&A, R&D, and Dept/Amort Expenses | 22.14 | 23.69 | 23.17 | 22.07 | 20.91 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 22.14 | 23.68 | 23.17 | 22.07 | 20.91 |
Income Taxes | 0.43 | 0.37 | 0.42 | 0.35 | 0.34 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | -1.32 | 4.69 | 8.11 | 0.90 | 2.01 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 20.39 | 28.01 | 30.86 | 22.62 | 22.58 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 20.39 | 28.01 | 30.86 | 22.62 | 22.58 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 37.06 | 37.06 | 37.23 | 37.06 | 37.06 |
Diluted EPS Before Non-Recurring Items | 0.59 | 0.63 | 0.61 | 0.59 | 0.56 |
Diluted Net EPS (GAAP) | 0.55 | 0.76 | 0.87 | 0.61 | 0.61 |